Deepak R. Talreja, M.D., discusses the current advances in lipidology. Here he discusses lipid management that utilizes PCSK9 inhibitors, how these effect cholesterol, how to determine if your patient is a candidate for this type of treatment, and what complications one might expect from this treatment.
Related Presenters
Medical Education M.D. - Univ of Virginia School of Medicine - 1997 Medical Experience Fellowship - Mayo Graduate Sch of Medicine - 2004 Internship - Vanderbilt University Medical Center - 1998 Residency - Vanderbilt University ...
Related Videos
